Zelira Therapeutics Upholds Strong Corporate Governance
Company Announcements

Zelira Therapeutics Upholds Strong Corporate Governance

Zelira Therapeutics (AU:ZLD) has released an update.

Zelira Therapeutics Limited has affirmed its commitment to corporate governance in line with ASX guidelines, disclosing that its practices are fully compliant throughout the reported period. The company’s governance statement and board charter details are accessible on their website, ensuring transparency for shareholders and stakeholders. The statement, current as of 28 August 2024, is board-approved and can be found at https://zeliratx.com/corporate-governance/

For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskZelira Therapeutics’ Financials: Borrowings Boost Cash Flow
TipRanks Australian Auto-Generated NewsdeskZelira Therapeutics Advances in FDA Trials and Product Development
TipRanks Australian Auto-Generated NewsdeskZelira Therapeutics Schedules Hybrid 2024 AGM
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App